☰
  • Home
  • Blog
  • Policy Papers
  • Analysis
  • Report Cards
  • Summits
  • You’re Invited
Logo
  • Blog
  • Policy Papers
  • Report Cards
  • Analysis
  • Summits

Biomarker Testing: Allowing Individualized Treatment for Cancer Patients

March 24, 2022

Biomarkers are predictive markers in genetic material that can indicate which medications might work for a given patient. For cancer patients, biomarker testing is an important first step toward tailored treatment.

Read Paper

Tags: Biomarker Testing, Oncology

Categorized in: Policy Briefs, Policy Papers

Recent Blog Posts

Pharmacists Poised to Play Larger Role in Uptake of Biosimilars May 13, 2022
New Medication Offers New Hope for Heart Patients May 11, 2022
Alzheimer’s Patients Dealt a Devastating Blow May 9, 2022

2020 K Street NW, Suite 505 Washington, DC 20006 (202) 964-2624

About Us Archive

© 2022 Copyright Institute for Patient Access